Tumor size is an unreliable predictor of prognosis in basal-like breast cancers and does not correlate closely with lymph node status
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/content/pdf/10.1007/s10549-008-0102-6.pdf
Reference23 articles.
1. Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI et al (2002) Revision of the American Joint Committee on cancer staging system for breast cancer. J Clin Oncol 20(17):3628–3636. doi: 10.1200/JCO.2002.02.026
2. Carter CL, Allen C, Henson DE (1989) Relation of tumor size, lymph node status, and survival in 24, 740 breast cancer cases. Cancer 63:181–187. doi :10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H
3. Foulkes WD, Metcalfe K, Hanna W, Lynch HT, Ghadirian P, Tung N et al (2003) Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma. Cancer 98(8):1569–1577. doi: 10.1002/cncr.11688
4. Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA et al (2007) Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 13(15 Pt 1):4429–4434. doi: 10.1158/1078-0432.CCR-06-3045
5. Cheang MC, Voduc D, Bajdik C, Leung S, McKinney S, Chia SK et al (2008) Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res 14(5):1368–1376. doi: 10.1158/1078-0432.CCR-07-1658
Cited by 74 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. DDR2 expression in breast cancer is associated with blood vessel invasion, basal-like tumors, tumor associated macrophages, regulatory T cells, detection mode and prognosis;Human Pathology;2024-08
2. Association of Breast Cancer Subtypes and Clinicopathological Factors with Axillary Lymph Node Positivity Amongst Women with Breast Cancer in Rajasthan: An Observational Analytical Study;Indian Journal of Surgical Oncology;2024-06-19
3. Molecular testing in breast cancer;Diagnostic Molecular Pathology;2024
4. Novel Implications of Prognostic Markers to Monitor the Disease: An Overview;Therapeutic Drug Targets and Phytomedicine For Triple Negative Breast Cancer;2023-01
5. BREAST CANCER IN WOMEN YOUNGER THAN 35 YEARS OLD: IMMUNOHISTOCHEMICAL AND MOLECULAR CHARACTERISTICS AND IMAGING DIAGNOSIS;Revista Medico-Chirurgicala;2022-12-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3